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in the context of autoimmune disease pathogenesis.
We have investigated the responses of male and fe-
male mice to neonatal injection of an ovarian-specificSummary
peptide, ZP3330–342 (pZP3). ZP3 is one of three major gly-
coproteins in the zona pellucida, which surrounds allNeonatal female mice injected with the self ZP3 pep-
developing and ovulated oocytes (Dean, 1992). It func-tide are not tolerant to the peptide; they develop auto-
tions as the primary sperm receptor for fertilization andimmune ovarian disease (AOD) and autoantibody re-
is accessible to circulating antibodies and CD41 T cellssponse 5 weeks later. ZP3 challenge leads to severe
(Dean, 1992; Accini et al., 1980; Matsuo et al., 1985;AOD and ZP3-specific T cell and antibody responses.
Rhim et al., 1992). pZP3 contains two nested T cellIn contrast, neonatal tolerance to foreign ZP3 peptide
epitopes and a native B cell epitope (Rhim et al., 1992;is established in male mice:ZP3 peptide–specific T cell
Garza and Tung, 1995). It has the capacity to induceproliferative response is reduced and AOD is absent in
autoimmune ovarian disease (AOD) in the endogenousovarian grafts. Tolerance is associated with a Th2-
ovaries of female mice and in ovarian grafts of maledominant T cell cytokine and antibody isotype profiles.
mice (Rhim et al., 1992; unpublished data). AOD, trans-As controls, neonatal tolerance to foreign peptides,
ferrable to normal mice with CD41 T cells but not bywith Th2 deviation, was induced in both male and fe-
antibodies (Rhim et al., 1992; Lou et al., 1995), is a modelmale mice. Endogenous ZP3 is important for the gen-
of human autoimmune ovarian failure and the autoim-der difference. Ablation of ovaries in female mice on
mune polyendocrinopathy syndrome (Laberbera et al.,days 2 and 5, but not on day 7 or 14, switches the ZP3
1988; Tung and Lu, 1991). Because ZP3 is female spe-autoimmune response to a tolerogenic response with
cific, this autoimmune model provides a unique opportu-a concomitant change in cytokine profile. Thus, neo-
nity to compare the response of male mice to the foreignnatal self ZP3 peptide, supported by endogenous ova-
pZP3 with the response of female mice to self pZP3 inries within a neonatal time window, evokes a patho-
the same mouse strain.genic autoimmune response.
In this paper, we show that the injection of pZP3 into
neonatal female mice results in an autoimmune re-Introduction
sponse to pZP3 and the mice develop AOD. Most impor-
tantly, the autoimmune response to the neonatal pZP3The injection of cellular alloantigen in neonatal mice can
injection occurs only in animals that possess their en-lead to a state of antigen-specific unresponsiveness as
dogenous ovaries during the neonatal period. Malemanifested by the lack of allogeneic tissue graft rejec-
mice, and females whose ovaries have been removedtion (Billingham et al., 1953). This seminal observation,
within a critical neonatal time window, develop a Th2-which led to the concept that physiological tolerance
deviated response to pZP3, without AOD. The relevanceis established early in ontogeny through self antigen
of these findings to the pathogenesis of Th1-dominantexposure, was supported by subsequent studies based
autoimmune diseases and the perception of neonatalon soluble proteins and peptides (Young and Atassi,
self antigens by the immune system is discussed.1983; Clayton et al., 1989; Qin et al., 1989; Gammon et
al., 1986). However, several recent studies have de-
scribed the capacity of mice to respond to minor histo- Results
compatibility antigens, viral antigens, and foreign or self
proteins or peptides injected in the neonatal period Neonatal Injection of Female Mice with Self
pZP3 Induces AOD(Ridge et al., 1996; Sarzotti et al., 1996; Forsthuber et
al., 1996; Singh et al., 1996). In the case of male-specific Female (C57BL/6 3 A/J)F1 (B6AF1) mice were injected
on days 1 and 3 with a total dose of 40 mg of pZP3HY antigen, neonatal injection of male dendritic cells
primed cytotoxic T cells (Ridge et al., 1996). Viral immu- in incomplete Freund’s adjuvant (IFA). At 5–6 weeks,
approximately 40% of the mice had AOD (Table 1; Figurenity was established following neonatal injection of the
whole virus (Sarzotti et al., 1996). For soluble proteins 1B) and over 60% had pZP3-specific serum antibodies
(Table 2). At this time, theproliferative response of lymphor peptides, a dominant T helper type 2 (Th2) response
was elicited (Forsthuber et al., 1996), and in one case node cells (LNC) or spleen cells to pZP3 was positive
but low, with stimulation indices of z3 (data not shown).the Th2 response resulted in the development of an
autoantibody-mediated disease (Singh et al., 1996). Col- However, after they were challenged with pZP3 in com-
plete Freund’s adjuvant (CFA) at 6 weeks and studiedlectively, these studies indicate that the consequences
of neonatal antigenic challenge can vary and may not 2 weeks later, their LNC proliferative responses to pZP3
were identical to that of age-matched controls (Figurenecessarily be toward a state of tolerance. Factors that
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Table 1. AOD in Mice Injected with pZP3 Neonatally, as Adults, or Both
Disease before Adult Challenge Disease after Adult Challenge
Neonatal Mean Mean
Sex Treatment Incidence (%) Score Incidence (%) Score
Female None 0 of 10 0 22 of 24 (92) 2.1
Female IFA alone 0 of 10 0 9 of 11 (82) 2.7
Female pZP3 plus IFA 7 of 17 (41) 1.7 20 of 22 (91) 2.6
Male None na 10 of 10 (100) 2.5
Male IFA alone na 7 of 9 (78) 2.1
Male pZP3 plus IFA na 0 of 10 0
Histopathology of AOD was determined before adult challenge (at 5–6 weeks following neonatal treatment) and/or after adult challenge with
peptide in CFA at 6 weeks and studied 2 weeks later. Male mice received ovarian grafts from syngeneic female donors at 6 weeks and were
studied 2 weeks later. na, not applicable.
2A). AOD that developed was more severe (Figure 1C; of the female mice that were neonatally injected and
adult challenged with pZP3 produced concentrations ofTable 1), and the level of ZP3 antibody response was
10 times higher than that of mice studied before chal- interferon-g (IFNg) and interleukin-4 (IL-4) comparable
with control animals (Figures 3A and 3B). The immuno-lenge with pZP3 (Table 2). In response to pZP3, the LNC
Figure 1. Histopathology of AOD
Inflammation is detected in the following groups of mice: adult females injected with pZP3 in CFA (A); 5-week-old females injected with pZP3
in IFA as neonates (B); females injected neonatally with pZP3 in IFA and as adults with pZP3 in CFA (C); ovarian implant in adult males injected
with pZP3 in CFA (E). Arrows point to infiltration of macrophages and lymphocytes in inflamed atretic follicles. Ovarian inflammation is absent
in (D) ovarian graft of neonatally ovariectomized females injected with pZP3 in IFA as neonates, followed by pZP3 in CFA as adults, and (F)
ovarian graft of male mice injected neonatally with pZP3 in IFA and pZP3 in CFA as adults. All ovaries, except those in (B), were studied at
8 weeks. Staining is with hematoxylin and eosin; magnification is 3200 for (A) and (C), 3400 for (B) and (E), and 3100 for (D) and (F).
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Table 2. pZP3 Antibody Response following Neonatal or Adult pZP3 Immunization or Both
Antibody Incidence (mean ELISA Units)
Neonatal
Sex Treatment Before Adult Challenge After Adult Challenge
Female None 0 of 9 16 of 17 (133)
Female IFA alone 0 of 15 15 of 15 (295)
Female pZP3 plus IFA 9 of 13 (89) 21 of 22 (905)
Male None 0 of 6 8 of 8 (324)
Male IFA alone 0 of 10 9 of 10 (408)
Male pZP3 plus IFA 8 of 16 (257) 11 of 13 (909)
Incidence and titers of serum antibody to pZP3 were determined at 6 weeks, prior to adult challenge, and at 8 weeks, 2 weeks after adult
peptide challenge. pZP3-specific antibodies were detected by ELISA.
globulin G1 (IgG1):IgG2 isotype ratios of their serum AOD also developed in the ovarian graft implantedunder
their kidney capsules at the time of immunization (Tableantibodies to pZP3 were also comparable (Figure 3C).
1; Figure 1E). However, when male mice were injectedTherefore, female mice are not tolerized by neonatal
neonatally with pZP3 in IFA and challenged with pZP3injection of pZP3. Instead, neonatal injection of pZP3 in
in CFA 6 weeks later, they had negligible ZP3 peptide–IFA induces AOD and autoantibodies to pZP3 within 5
specific LNC proliferative responses (Figure 2B). Theirweeks. Subsequent challenge with pZP3 in CFA results
ovarian grafts were free of AOD (Table 1; Figure 1F).in a strong recall response. That the autoimmune re-
Nevertheless, when their LNC were stimulated withsponse to neonatally administered pZP3 is critically de-
pZP3, they produced IL-4, whereas the LNC of controlpendent on endogenous ovarian antigen is shown in
males injected with IFA as neonates produce minimalsubsequent studies.
IL-4 (p 5 0.003) (Figure 3B). The LNC from males injected
neonatally with pZP3 also produced significantly lessNeonatal Injection of Male Mice with Foreign
IFNg than LNC of nontolerized adult males when studiedpZP3 Induces a Th2-Dominant
after adult challenge with pZP3 (p 5 0.016) (Figure 3A).Nonpathogenic Response
IgG antibodies to pZP3 were detected in 50% of theMale B6AF1 mice injected with pZP3 in CFA developed
pZP3-tolerized male mice 5 weeks after neonatal pep-a strong LNC proliferative response to pZP3 (Figure 2B).
tide injection, and the levels increased 4- to 5-fold after
pZP3 challenge at 6 weeks (Table 2). When the antibod-
ies obtained after adult pZP3 challenge were analyzed,
Figure 2. Neonatal Immunization of Female Mice with pZP3 Does
Not Inhibit pZP3-Specific LNC Proliferative Responses upon Adult Figure 3. T Cell Cytokine Profile and pZP3 Antibody Isotype Analy-
sis Indicate That Only Male Mice Injected Neonatally with pZP3Challenge
Develop a Th2-Dominant Response to pZP3Female (circles) and male (squares) mice were immunized intraperi-
toneally 24 hr and 78 hr postnatally with IFA alone (closed symbols) Production of IFNg (A) and IL-4 (B) by LNC from mice treated neona-
tally with IFA alone (closed bars) or with pZP3 in IFA (open bars)or with peptide in IFA (open symbols). The mice were injected with
pZP3 (A and B) or with two control foreign peptides, CP2 (C) and are shown. The cytokine data represent the mean 6 SEM of 10–22
mice. In (C) and (D), the ratio of peptide-specific IgG1:IgG2a inducedpMCC (D). At 6 weeks, the mice were challenged with the indicated
peptide emulsified in CFA; 2 weeks later, LNC proliferative re- by pZP3 immunization of adult female (circles) and male (squares)
mice that were neonatally immunized with IFA alone (closed sym-sponses to the immunogen were determined. Shown are one of
three studies on pZP3 immunizations and one of two studies on CP2 bols) or with pZP3 in IFA (open symbols) is shown. Antibody isotype
ratio (mean 6 SEM) is one of two representative experiments, withand pMCC immunizations; five mice were studied per experiment.
Results are expressed as mean 6 SEM. Animals unresponsive to five mice per group. At 6 weeks, all animals were injected with pZP3
in CFA. LNC and sera, obtained 2 weeks later, were studied forpeptide had normal responses to Mycobacterial extracts (Dcpm for
peptide-tolerized animals 5 78,543 6 10,974; for control responding IFNg and IL-4 production and for peptide-specific antibody ratio of
IgG1:IgG2a, respectively.animals 5 75,684 6 9,876).
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their relative IgG1:IgG2 ratio was 3-fold greater than that
of the nontolerized adult males immunized with pZP3
(Figure 3D).
The reduction of lymphocyte proliferative response to
pZP3 was specific for pZP3. The response of the LNC
to purified Mycobacterialantigens in theCFA was similar
to that of control males (Figure 2, legend). In addition,
when male mice were injected neonatally with pZP3 and
challenged as adults with a foreign peptide, CP2, the
mice produced strong lymphocyte proliferative re-
sponse to CP2 but not to pZP3 (data not shown). CP2
is a chimeric peptide composed of the bovine ribo-
nuclease T cell epitope (94–104) (Chen et al., 1991) and
a modified ZP3(336–343) sequence; its T cell epitope
does not cross-react with the pZP3 (Lou et al., 1995).
Figure 4. Female and Male Mice Neonatally Injected with CP2 orThus, neonatal pZP3 injection in male mice leads to
pMCC Develop Th2-Deviated Responses upon Challenge as Adultstolerance with respect to lymphocyte proliferative re-
with the Corresponding Peptidesponses and AOD induction. Also, in accordance with
Production of IFNg (A and C) and IL-4 (B and D) by mice injectedneonatal tolerance studies to alloantigens and several
with CP2 (A and B) and pMCC (C and D) was determined. The miceprotein antigens, the tolerance state is shifted from the
were neonatally immunized with IFA alone (closed bars) or with the
Th1-dominant response to a Th2-dominant response, peptide in IFA (open bars). All mice were challenged at 6 weeks
as shown by their cytokine profile and antibody isotypes with the corresponding peptide in CFA; 2 weeks later, LNC were
collected and in vitro stimulated with the immunizing peptide, and(Forsthuber et al., 1996; Singh et al., 1996; Powell and
supernatants were bioassayed for cytokine production.Streilein, 1989; Chen and Field, 1995).
Neonatal Immunization with Foreign Peptides
later. It was striking that the ovarian grafts in the females
Results in Dominant Th2 Responses
ovariectomized on days 2 and 5 after birth were free of
in Both Male and Female Mice
AOD (Table 3; Figure 1D). Although their LNC did not
To control for sex hormone and other gender effects, we
proliferate in response to pZP3 (Figure 5A), the culture
compared the male and female responses to neonatal supernatant contained detectable IL-4 and not IFNg
injection of two foreign peptides: CP2 and moth cyto- (Figure 5B). An enhanced antibody response was also
chrome C93–103 (pMCC). CP2 stimulated a comparable T observed (Table 3). Whereas the removal of the ovaries
cell response in normal adult male and female mice ondays 2 and 5 dramatically altered the female response
(Figure 2C). When the mice were injected neonatally with to neonatal injection of pZP3, this was not observed in
CP2 in IFA, and subsequently with CP2 in CFA, their
mice ovariectomized on day 7 or day 14 (Table 3; Figure
lymphocyte proliferative responses to CP2 were re-
5). Several controls were included for the neonatal ovari-
duced and, importantly, the reduction was comparable
ectomy experiment. First, females that were sham-
for the two sexes (Figure 2C). Figure 2D illustrates similar
operated, but immunized with pZP3 as neonates and
results for the pMCC responses. The cytokines pro-
challenged with pZP3 as adults, had positive LNC prolif-
duced by T cells from male and female adult mice immu-
erative responses (Figure 5A), their T cells produced
nized with CP2 or pMCC in CFA were equally enriched
both IFNg and IL-4 (Figure 5B), and they developed AOD
in IFNg, with no detectable IL-4 (Figure 4). However,
(Table 3). Second, mice that were neonatally ovariecto-
following peptide injection in the neonates, the IFNg mized and not immunized with pZP3, but challenged
levels were reduced, and IL-4 became detectable (Fig- with thepZP3 as adults, mounted the usual LNC prolifer-
ure 4). ative response to pZP3 (data not shown), and their ovar-
The responses of male and female mice to neonatal ian grafts developed AOD (Table 3). Third, neonatal
injection of the foreign peptides CP2 or pMCC are equal ovariectomized female mice, immunized with CP2 or
and are comparable with the response of male mice to pMCC as adults, did not produce Th2-dominant re-
the foreign pZP3. Therefore, the unique female autoim-
sponses (data not shown). Hence, neonatal ovariectomy
mune response to neonatal injection of pZP3 is not likely
per se does not favor a Th2-dominant response to anti-
based on ovarian hormone or other gender differences.
gens injected into neonates or adults.
Ovariectomy within a neonatal time window (between
days 5 and 7) has switched the autoimmune pathogenicNeonatal Ovariectomy at a Narrow Time Window
Converts the Female Response to Neonatal response to a Th2-dominant, nonpathogenic response
in female mice that receive neonatal injections of pZP3.Injection of pZP3 to a Th2-Dominant
Nonpathogenic Response The change hasspecifically resulted from neonatal ovar-
ian ablation, most likely from the loss of endogenousTo evaluate further the influence of endogenous ovarian
antigens on the unique female response to neonatally ZP3 at a critical time window soon after birth.
injected pZP3, we studied females that were ovariecto-
mized on days 2, 5, 7, and 14 after birth. Ovariectomized Discussion
mice were injected with pZP3 in IFA on days 1 and 3
after birth, and at 6 weeks they were challenged with Neonatal female mice, injected with an ovarian ZP3 pep-
tide, develop AOD at 5 weeks of age. This is associatedpZP3 in CFA, grafted with an ovary, and studied 2 weeks
Neonatal Induction of Ovarian Autoimmunity
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Table 3. AOD and pZP3 Antibody in Neonatally Ovariectomized Mice Injected with pZP3 Neonatally
Ovarian Disease
Mean Antibody Incidence
Neonatal Treatment Incidence (%) Score (Mean ELISA Units)
None 7 of 8 (88) 2.3 8 of 8 (132)
pZP3 plus IFA 6 of 6 (100) 2 6 of 6 (870)
Day 2 ovariectomy 8 of 8 (100) 2.5 8 of 8 (124)
pZP3 plus IFA and sham day 2 ox 6 of 6 (100) 2.2 4 of 4 (594)
pZP3 plus IFA and day 2 ovariectomy 0 of 8 0 8 of 8 (664)
pZP3 plus IFA and day 5 ovariectomy 1 of 8 (13) 1 8 of 8 (962)
pZP3 plus IFA and day 7 ovariectomy 8 of 10 (80) 1.75 10 of 10 (884)
pZP3 plus IFA and day 14 ovariectomy 6 of 9 (67) 1.8 9 of 9 (768)
Histopathology of AOD and serum pZP3 antibody titers were determined at 8 weeks, 2 weeks after adult pZP3 challenge. In ovariectomized
mice, AOD histopathology pertains to that in ovarian grafts implanted at 6 weeks of age.
with antibody response and a marginal proliferative T range from 4 to 400 mg, and it is possible for soluble
pZP3, given in saline to neonates, to induce a patho-cell response to the peptide. A subsequent challenge
genic response (K. M. G. and K. S. K. T., unpublishedwith the same peptide provoked a strong pathogenic
data). The autoimmune response to neonatal pZP3 in-autoimmune response without evidence of Th2 devia-
jection is critically dependent on the presence of endog-tion. Thus neonatal injection of a self peptide may not
enous ovaries. Thus, male mice injected neonatally withlead to tolerance, as described for foreign and some
the same ovarian peptide become tolerant to it. This isself peptides and proteins (Clayton et al., 1989; Qin et
manifest as the lack of disease in the ovarian graftsal., 1989; Gammon et al., 1986; Forsthuber et al., 1996;
and the reduction in pZP3-specific proliferative T cellSingh et al., 1996). It should be emphasized that the
response upon adult challenge. The tolerance state ineffective pZP3 dose for neonatal immunization can
the male mice is in fact an antigen-specific, Th2-devi-
ated response. They produce antibodies in 5 weeks,
and upon subsequent challenge with pZP3, their T cells
produce more IL-4 and less IFNg, and the antibodies of
the IgG1 isotype are enriched. The gender difference
is not responsible for the differential male and female
responses to the neonatally injected pZP3, as they re-
spond equally to neonatal injection of two foreign pep-
tides: CP2 and pMCC. In each case, the male and female
responses were equally reduced, both being Th2 de-
viated.
While the study suggests that neonates may have the
capacity to mount or prime a pathogenic autoimmune
response, the neonatally injected pZP3 in IFA may re-
main as an immunogenic depot and retain the capacity
to stimulate an autoimmune response beyond the neo-
natal period. This potential caveat in the interpretation of
the results has been resolved by the study on neonatally
ovariectomized mice. The autoimmune response in the
females following neonatal pZP3 injection is abrogated
in mice that have been neonatally ovariectomized, and,
interestingly, their response also becomes Th2 domi-
nant. Most importantly, the ovariectomy effect is ob-
served only when theovaries are removed within the first
6 days of life. This finding suggests that the pathogenic
autoimmune response in the female mice is dependent
on the stimuli of both endogenous ovarian antigen andFigure 5. Neonatal Ovariectomy within a Neonatal Time Window
the injected ZP3 peptide and that the response occursAlters the Female Response to Neonatal Injection of pZP3
in the first week of life. As an additional argument againstIn (A) the LNC proliferative responses of femalemice ovariectomized
the delayed antigen stimulus hypothesis, soluble pZP3on day 2 (open circle), day 5 (open square), day 7 (closed triangle),
that should not have a depot effect also induces AODday 14 (closed square), or sham operated on day 2 (closed circle)
postnatally are shown. Production of IFNg and IL-4 (B) by LNC when given to the neonates, and it primes neonatal fe-
from the corresponding experimental and control mice groups were male mice for AOD upon adult challenge (K. M. G. and
studied at the same time as their LNC proliferation assays. All data K. S. K. T., unpublished data).
are presented as means 6 SEM (n 5 8–10 per group). These mice
Why do female mice develop AOD when injected withwere injected on days 1 and 3 with pZP3 in IFA, boosted with
pZP3 as neonates, and could this be relevant to autoim-pZP3 in CFA at 6 weeks, and studied 2 weeks later. The females
mune pathogenesis? There is evidence that the neonatalovariectomized on day 2 or 5 had normal LNC proliferative re-
sponses to Mycobacterial extracts (mean Dcpm 5 68,431 6 5,629). T cell repertoire is enriched in autoreactive pathogenic
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T cells. They contain high levels of forbidden Vb-specific antigens. Moreover, the alteration of the known sex ste-
roid hormones implicated in autoimmune disease sus-splenic T cells against endogenous superantigens, even
though these T cells are known to be deleted in the ceptibility would not be invoked because ovariectomy
on day 7 does not change the autoimmune neonataladult thymus (Schneider et al., 1989; Smith et al., 1989;
Jones et al., 1990). Moreover, neonatal spleens are en- response to pZP3 (Grossman, 1985; Beeson, 1994). Nev-
ertheless, the complete resolution of this issue will haveriched in pathogenic, autoreactive T cells for ovarian
antigens, including the zona pellucida. The transfer of to await a study of mice deficient in ZP3.
How do our findings impact on the concept of neona-3-day-old but not adult splenic CD41 T cells from normal
females was shown to induce a high incidence of AOD, tal tolerance and on the model of neonatal tolerance?
They do not negate in any way the concept of neonatalwith ovarian autoantibodies, in syngeneic athymic nu/
nu mice (Smith et al., 1992). Thus, the pathogenic T cell exposure to self antigens as a potential mechanism of
physiological tolerance induction. Our preliminary data,population of the normal neonatal females may respond
to the pZP3 injected in the neonate and be responsible mentioned above, would in fact support this contention.
On the other hand, our study has also made it clear thatfor the AOD. Neonatal immune responses to self anti-
gens may be pertinent to autoimmune disease patho- the classical tolerance model based on neonatal antigen
injection does not apply to all antigenic peptides. It isgenesis. Neonatal injection of a peptide from the VH
region of a monoclonal single-stranded DNA antibody, possible that neonatal tolerance, associated with a Th2-
dominant response, is induced experimentally onlywhich provokes a Th2-dominant response to the pep-
tide, is associated with the spontaneous appearance of against foreign antigens or self antigens that are largely
sequestered (Clayton et al., 1989; Qin et al., 1989; Gam-serum double-stranded DNAantibodies. It was hypothe-
sized that individuals exposed early in life to such a mon et al., 1986; Forsthuber et al., 1996; Singh et al.,
1996). The model may not apply to self antigens andpeptide may be predisposed to antibody-mediated au-
toimmune diseases such as systemic lupus erythemato- peptides, such as ZP3, that are readily accessible to
the immune system.sus (Singh et al., 1996), or even Th2-dependent allergic
diseases (Holt, 1996). In this context, the female neona- In summary, the study of the murine AOD model has
provided a unique opportunity for theanalysis of autoim-tal autoimmune response to the ZP3 peptide raises the
possibility that an early and perhapsexcessive exposure mune and nonautoimmune responses to the same gen-
der-specific ZP3 peptide. We have shown that neonatalto self antigen may predispose individuals to Th1-
dependent autoimmune diseases later in life. tolerance develops against the foreign but not the ac-
cessible self antigen. Even more importantly, the pres-The critical neonatal time window required for the
ovariectomy effect provides strong support for the likeli- ence of endogenous ovaries at a critical neonatal time
window, perhaps by providing endogenous ZP3, canhood that endogenous ovarian antigens are normally
perceived by the neonatal immune system. The nature modify the immune response to neonatal ovarian self
peptide immunization, changing it from a tolerogenicof this ovarian self antigen exposure is manifest as a
pathogenic autoimmune response when the neonatal response to an autoimmune response.
mice are also given the pZP3 as neonates. How the self
Experimental Proceduresovarian antigenic stimulus is perceived in the normal
neonatal female mice remains to be fully established.
AnimalsHowever, our preliminary data support the likelihood
A B6AF1 colony was established by breeding C57BL/6 females and
that neonatal ovarian self antigen participates in estab- A/J males purchased from the National Cancer Institute (Frederick,
lishing physiological tolerance to ZP3. Compared with MD). Adult B6AF1 female and male mice (6–8 weeks) were also
normal females, adult females that are neonatally ovari- purchased from National Cancer Institute. Treatment of mice was
in accordancewith the National Institutesof Healthguidelines estab-ectomized (without neonatal peptide injection) mount a
lished at the University of Virginia.stronger T cell response to pZP3, and their pZP3-spe-
cific T cells produce more IFNg and less IL-4; these
Induction of Neonatal Tolerance and AODaltered responses are pZP3 specific (K. M. G. and
To induce tolerance to peptides, B6AF1 neonates were injected
K. S. K. T., unpublished data). intraperitoneally at 24 and 72 hr postnatally with 20 mg of peptide
The effect of neonatal ovarian ablation may not be emulsified in IFA. Control mice received IFA alone. AOD was induced
due solely to the depletion of ovarian antigens; ovarian in adult female and male B6AF1 mice (6–8 weeks) by injection of a
peptide and adjuvant emulsion into one hind footpad and the basehormones or factors are also removed. However, we
of the tail. The adjuvant emulsion consisted of equal volumes of CFAhave shown that neonatal ovariectomy per se does not
containing 1 mg/ml Mycobacterium tuberculosis (Fisher Biotech.,nonspecifically favor a Th2-dominant response. More-
Fairlawn, NJ) and 50 nmol of solubilized peptide. Male mice and
over, it is known that a large cohort of oocytes degener- ovariectomized females received an ovarian graft at the time of adult
ates in the normal murine ovaries in the first 2 weeks of immunization.
life, and many are extruded into the peritoneal cavity
(Byskov and Rasmussen, 1978; Hirshfield, 1991). Ovari- Surgery
For neonatal ovariectomy, 2-, 5-, 7-, or 14-day-old females wereectomy in the first week should substantially reduce
anesthetized with halothane (Halocarbon Laboratories, North Au-oocyte antigen exposure to the immune system in the
gusta, SC). Via lowerback incisions, the ovaries wereremoved underneonates. Even if ovarian factors or hormones were in-
a dissecting microscope, and the incision was closed with 9.0 or
volved, the narrow time window of the ovarian ablation 8.0 silk (Surgical Specialties Group, Reading, PA). For adult ovariec-
effect means that depletion of some novel factor(s) pro- tomies, 6- to 8-week-old females were anesthetized with tribromo-
duced by neonatal ovaries is responsible for this effect, ethanol (0.6 mg per25 g of body weight), and one ovarywas removed
via a lower back incision. To implant ovarian isografts, an ovarythe impact of which is confined to a response to ovarian
Neonatal Induction of Ovarian Autoimmunity
95
from a 6- to 8-week-old female was surgically inserted under the Sample supernatant (50 ml) was added to triplicate wells together
with 50 ml of LPS (80 ng/ml in complete DMEM). After 24 hr at 378C,renal capsule of the anesthetized recipient through a small capsular
incision. All skin wounds were closed with 4.0 silk (Surgical Speciali- the supernatants (70 ml) were transferred to microtiter plates. Equal
volumes of solutions A (0.1% naphthylenediamine dihydrochlorideties Group).
in distilled water) and B (1% sulphanilamide in 5% concentrated
H3PO4) (Sigma) were premixed, and 70 ml of the mixture was added.Histological Assessment of AOD
The absorbance at 540 nm was determined. IFNg levels were cal-Ovaries were fixed in Bouin’s fixative and embedded in paraffin. We
culated against murine recombinant IFNg (R&D Systems, Minneapo-stained 30 to 50 serial step sections per ovary, 5 mm thick, with
lis, MN).hematoxylin and eosin. Histopathology was evaluated as coded
To detect IL-4, LNC from peptide-immunized mice were stimu-unknown specimens, and AOD severity was graded from 1 to 4 as
lated in vitro with 30 mM peptide at 3 3 106 cells per milliliter. Onfollows: 1 was focal inflammation in interstitial space; 2 and 3 were
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CD3 antibody (145-2C11; Accurate Chemical and Scientific Corp.,ovarian atrophy (Rhim et al., 1992).
Westbury, NY). The anti-CD3 antibody enhances cytokine produc-
tion by clonally expanded peptide-specific T cells and allows anPeptides
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for 18 hr at 378C, 5% CO2. The plates were then pulsed with 0.5 mCicolumn (POROS II R/H; 4.6 mmD/100 mmL; PerSeptive Biosystems,
per well of [3H]thymidine; 8 hr later, the cells were harvested andCambridge, MA). The purity of all peptides exceeded 90%.
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